Fundraising Fox큐라클
1 known investors
Find your way into 큐라클
Sign up to see every warm intro you have to 큐라클
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 큐라클 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Curacle develops first-in-class therapies aimed at restoring microvascular function in aging and chronic diseases, including small molecules via its SOLVADYS platform and biologics via its EAGLES platform. Its pipeline addresses conditions such as macular degeneration.
Investors · 1
Frequently asked questions
- What does 큐라클 do?
- Curacle develops first-in-class therapies aimed at restoring microvascular function in aging and chronic diseases, including small molecules via its SOLVADYS platform and biologics via its EAGLES platform. Its pipeline addresses conditions such as macular degeneration.
- Who are 큐라클's investors?
- 큐라클's investors include Hyundai Venture Investment Corporation.